Farley J. Abad

Array ( [id] => 517380 [patent_doc_number] => 07193058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'ULBP antibodies' [patent_app_type] => utility [patent_app_number] => 10/875869 [patent_app_country] => US [patent_app_date] => 2004-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 28276 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/193/07193058.pdf [firstpage_image] =>[orig_patent_app_number] => 10875869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905492 [patent_doc_number] => 20050100887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Targets for hepatitis C virus infections' [patent_app_type] => utility [patent_app_number] => 10/872645 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9330 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100887.pdf [firstpage_image] =>[orig_patent_app_number] => 10872645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971308 [patent_doc_number] => 20050037018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'HCV combination therapy' [patent_app_type] => utility [patent_app_number] => 10/871704 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18470 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037018.pdf [firstpage_image] =>[orig_patent_app_number] => 10871704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033536 [patent_doc_number] => 20050032045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Chimeric adenovirus capsid proteins' [patent_app_type] => utility [patent_app_number] => 10/866013 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20364 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032045.pdf [firstpage_image] =>[orig_patent_app_number] => 10866013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918900 [patent_doc_number] => 20050096461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Cysteine variants of erythropoietin' [patent_app_type] => utility [patent_app_number] => 10/866580 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27031 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096461.pdf [firstpage_image] =>[orig_patent_app_number] => 10866580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7157117 [patent_doc_number] => 20050027115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Cationic lipid-mediated enhancement of nucleic acid immunization of cats' [patent_app_type] => utility [patent_app_number] => 10/864903 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11256 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20050027115.pdf [firstpage_image] =>[orig_patent_app_number] => 10864903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275092 [patent_doc_number] => 20040234543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Vaccine formulation potentiated by the combination of a dna and an antigen' [patent_app_type] => new [patent_app_number] => 10/484112 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4885 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234543.pdf [firstpage_image] =>[orig_patent_app_number] => 10484112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249624 [patent_doc_number] => 20040258694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Hepatitis C receptor protein CD81' [patent_app_type] => new [patent_app_number] => 10/859700 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9945 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258694.pdf [firstpage_image] =>[orig_patent_app_number] => 10859700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208785 [patent_doc_number] => 20050053617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Modified HCV NS3' [patent_app_type] => utility [patent_app_number] => 10/855896 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14957 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053617.pdf [firstpage_image] =>[orig_patent_app_number] => 10855896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122307 [patent_doc_number] => 20050014136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Modified HCV NS5' [patent_app_type] => utility [patent_app_number] => 10/855897 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16418 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014136.pdf [firstpage_image] =>[orig_patent_app_number] => 10855897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060987 [patent_doc_number] => 20050003348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Hepatitis C virus NS5B polymerase inhibitor binding pocket' [patent_app_type] => utility [patent_app_number] => 10/842046 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 351 [patent_figures_cnt] => 351 [patent_no_of_words] => 15120 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003348.pdf [firstpage_image] =>[orig_patent_app_number] => 10842046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7210655 [patent_doc_number] => 20050053921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Systems for screening anti-hepatitis drugs' [patent_app_type] => utility [patent_app_number] => 10/837874 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6607 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053921.pdf [firstpage_image] =>[orig_patent_app_number] => 10837874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419255 [patent_doc_number] => 20040228878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Recombinant infectious laryngotracheitis virus and uses thereof' [patent_app_type] => new [patent_app_number] => 10/836383 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 25259 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228878.pdf [firstpage_image] =>[orig_patent_app_number] => 10836383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060592 [patent_doc_number] => 20050002952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Adjuvant for vaccine composition' [patent_app_type] => utility [patent_app_number] => 10/834616 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3945 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002952.pdf [firstpage_image] =>[orig_patent_app_number] => 10834616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045612 [patent_doc_number] => 20070264285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 10/554625 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23122 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264285.pdf [firstpage_image] =>[orig_patent_app_number] => 10554625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784260 [patent_doc_number] => 20060204476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Treating hepatocellular carcinomas using therapeutic viruses' [patent_app_type] => utility [patent_app_number] => 10/554337 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1655 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204476.pdf [firstpage_image] =>[orig_patent_app_number] => 10554337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060985 [patent_doc_number] => 20050003346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Apparatus and method for detecting microscopic living organisms using bacteriophage' [patent_app_type] => utility [patent_app_number] => 10/823294 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14611 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003346.pdf [firstpage_image] =>[orig_patent_app_number] => 10823294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427494 [patent_doc_number] => 20040209246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors' [patent_app_type] => new [patent_app_number] => 10/818075 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9339 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209246.pdf [firstpage_image] =>[orig_patent_app_number] => 10818075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996294 [patent_doc_number] => 20050136072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Pharmaceutical composition containing disrupted cell suspension of monilia albicans and euglobulin and method of treating animals infected with canine distemper virus of animals having neurological disorders by using the same' [patent_app_type] => utility [patent_app_number] => 10/816067 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4004 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136072.pdf [firstpage_image] =>[orig_patent_app_number] => 10816067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813098 [patent_doc_number] => 20060083735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Antigen-presenting complex-binding compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/510229 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 34423 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20060083735.pdf [firstpage_image] =>[orig_patent_app_number] => 10510229 [rel_patent_id] =>[rel_patent_doc_number] =>)